Asracef T 250mg/31.25mg Injection
Marketer
Asrawell Lifecare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Asracef T 250mg/31.25mg Injection
Asracef T, a 250mg/31.25mg injectable combination drug, combats various bacterial infections by inhibiting microbial growth and propagation. Administration must be overseen by a medical professional; consistent adherence to the prescribed schedule is crucial, completing the full course regardless of symptom improvement. Premature cessation may compromise its effectiveness. Common side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms warrant immediate medical attention. Seek immediate help for allergic reactions such as rashes, itching, swelling, or respiratory distress. Inform your physician of all current medications, and pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't affect driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, a balanced diet, and sufficient hydration promote faster recovery. Your doctor might order blood tests and other diagnostic procedures to monitor treatment response.
Uses of Asracef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Asracef T 250mg/31.25mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
Common Side effects of Asracef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Asracef T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Asracef T 250mg/31.25mg Injection works:
Asracef T Injection, containing 250mg Ceftriaxone and 31.25mg Tazobactam, utilizes a dual-action approach to combat bacterial infections. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering bacterial growth and survival. Tazobactam, a beta-lactamase inhibitor, complements Ceftriaxone by overcoming bacterial resistance mechanisms, thereby improving the antibiotic's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Asracef T 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Asracef T 250mg/31.25mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Asracef T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Asracef T 250mg/31.25mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Asracef T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Asracef T 250mg/31.25mg Injection with careful monitoring; dosage modification may be necessary. Medical advice is recommended. Dosage alteration for Asracef T 250mg/31.25mg Injection is unnecessary in individuals with mild or moderate liver dysfunction.
What if you forget to take Asracef T 250mg/31.25mg Injection :
Omit a scheduled Asracef T 250mg/31.25mg Injection? Seek medical advice immediately.
Facts to Know About Asracef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Antimicrobial agents |
3,018 People bought this recently